- Home
- CDNA vs PGRE Comparison
CDNA vs PGRE Comparison
Compare CDNA & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- PGRE
- Stock Information
- Founded
- CDNA 1998
- PGRE 1978
- Country
- CDNA United States
- PGRE United States
- Employees
- CDNA N/A
- PGRE N/A
- Industry
- CDNA Medical Specialities
- PGRE Real Estate Investment Trusts
- Sector
- CDNA Health Care
- PGRE Real Estate
- Exchange
- CDNA Nasdaq
- PGRE Nasdaq
- Market Cap
- CDNA 1.0B
- PGRE 953.6M
- IPO Year
- CDNA 2014
- PGRE 2014
- Fundamental
- Price
- CDNA $15.00
- PGRE $4.69
- Analyst Decision
- CDNA Buy
- PGRE Hold
- Analyst Count
- CDNA 8
- PGRE 3
- Target Price
- CDNA $28.14
- PGRE $4.33
- AVG Volume (30 Days)
- CDNA 940.1K
- PGRE 3.4M
- Earning Date
- CDNA 04-30-2025
- PGRE 04-30-2025
- Dividend Yield
- CDNA N/A
- PGRE 0.75%
- EPS Growth
- CDNA N/A
- PGRE N/A
- EPS
- CDNA 1.07
- PGRE N/A
- Revenue
- CDNA $346,421,000.00
- PGRE $711,729,000.00
- Revenue This Year
- CDNA $13.28
- PGRE $1.17
- Revenue Next Year
- CDNA $15.13
- PGRE N/A
- P/E Ratio
- CDNA $13.96
- PGRE N/A
- Revenue Growth
- CDNA 25.92
- PGRE 49.28
- 52 Week Low
- CDNA $7.42
- PGRE $3.75
- 52 Week High
- CDNA $34.84
- PGRE $5.47
- Technical
- Relative Strength Index (RSI)
- CDNA 31.37
- PGRE 67.68
- Support Level
- CDNA $14.86
- PGRE $4.10
- Resistance Level
- CDNA $18.71
- PGRE $4.43
- Average True Range (ATR)
- CDNA 0.98
- PGRE 0.15
- MACD
- CDNA -0.24
- PGRE 0.05
- Stochastic Oscillator
- CDNA 3.08
- PGRE 92.31
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.